BIORA THERAPEUTICS, INC. 4 SEC Filings

Filed On	Filing
16 Dec 2024	Form 4: Athyrium Opportunities Iii Co-Invest 1 Lp, Director and 8 others Granted 0 11.00% / 13.00% Convertible Senior Secured Notes due 2028
16 Aug 2024	Form 4: Mohanty Aditya P., Director Gave up 70,883 shares to cover exercise price or tax ($47.5K)
16 Aug 2024	Form 4: Neumann Clarke, See Remarks Gave up 26,629 shares to cover exercise price or tax ($17.8K)
16 Aug 2024	Form 4: dEsparbes Eric, Chief Financial Officer Gave up 27,830 shares to cover exercise price or tax ($18.6K)
14 Aug 2024	Form 4: Athyrium Opportunities Iii Co-Invest 1 Lp, Director and 8 others Disposed of 0 11.00%/13. 00% Convertible Senior Secured Notes due 2028 (Disposition to Issuer) · Granted 0 11.00%/13. 00% Convertible Senior Secured Notes due 2028 · Disposed of 8,405,993 Warrant (Disposition to Issuer) · 1 more
08 Jul 2024	Form 4: Athyrium Opportunities Iii Co-Invest 1 Lp, Director and 8 others Granted 457,250 Warrant
05 Jul 2024	Form 4: Athyrium Opportunities Iii Co-Invest 1 Lp, Director and 8 others Granted 0 11.00%/13.00% Convertible Senior Secured Notes due 2028
06 Jun 2024	Form 4: Powell Lynne, Director Received 12,500 shares as a grant or award · Granted 12,500 Stock Option (Right to Buy)
06 Jun 2024	Form 4: Howe Jill Ann, Director Received 12,500 shares as a grant or award · Granted 12,500 Stock Option (Right to Buy)
06 Jun 2024	Form 4: Kotzin Brian L., Director Received 12,500 shares as a grant or award · Granted 12,500 Stock Option (Right to Buy)
06 Jun 2024	Form 4: Alter Jeffrey D., Director Received 12,500 shares as a grant or award · Granted 12,500 Stock Option (Right to Buy)
15 Feb 2024	Form 4: dEsparbes Eric, Chief Financial Officer Received 325,000 shares as a grant or award
15 Feb 2024	Form 4: Neumann Clarke, See Remarks Received 230,000 shares as a grant or award
15 Feb 2024	Form 4: Mohanty Aditya P., Chief Executive Officer Received 819,000 shares as a grant or award
20 Dec 2023	Form 4: Athyrium Opportunities Iii Co-Invest 1 Lp, Director and 8 others Granted 17,383,000 11.00% / 13.00% Convertible Senior Secured Notes due 2028 · Granted 7,124,608 Warrant · Disposed of 53,500,000 7.25% Convertible Senior Notes due 2025 (Disposition to Issuer)
19 Sep 2023	Form 4: Athyrium Opportunities Iii Co-Invest 1 Lp, Director and 8 others Received 9,235,281 shares as a grant or award · Disposed of 50,000,000 7.25% Convertible Senior Notes due 2025 (Disposition to Issuer) · Granted 24,033,733 Warrant
17 Aug 2023	Form 4: Neumann Clarke, See Remarks Gave up 36,183 shares to cover exercise price or tax ($114K) · Received 210,175 shares as a grant or award
17 Aug 2023	Form 4: dEsparbes Eric, Chief Financial Officer Gave up 40,022 shares to cover exercise price or tax ($126K) · Received 219,650 shares as a grant or award
17 Aug 2023	Form 4: Mohanty Aditya P., Director Gave up 117,881 shares to cover exercise price or tax ($370K) · Received 559,450 shares as a grant or award
16 Jun 2023	Form 4: Kotzin Brian L., Director Received 12,500 shares as a grant or award · Granted 12,500 Stock Option (Right to Buy)

Comments